Muscle-specific microRNAs as biomarkers of Duchenne Muscular Dystrophy progression and response to therapies

References

• Mendell JR, Boué DR, Martin PT. The con- genital muscular dystrophies: recent advances and molecular insights. Pediatr Dev Pathol 2006; 9:427-43; PMID:17163796; http://dx.doi.org/10.2350/06-07-0127.1
   PubMed Web of Science ®Google Scholar
• Dalkilic I, Kunkel LM Muscular dystrophies: genes to pathogenesis. Curr Opin Genet Dev 2003; 13:231-38; PMID:12787784; http://dx.doi.org/10.1016/S0959-437X(03)00048-0
   PubMed Web of Science ®Google Scholar
• Serrano AL, Mann CJ, Vidal B, Ardite E, Perdiguero E, Muñoz-Cánoves P. Cellular and molecular mechanisms regulating fibrosis in skeletal muscle repair and disease. Curr Top Dev Biol 2011; 96:167-201; PMID:21621071; http://dx.doi.org/10.1016/B978-0-12-385940-2.00007-3
   PubMed Web of Science ®Google Scholar
• Mozzetta C, Consalvi S, Saccone V, Tierney M, Diamantini A, Mitchell KJ, Marazzi G, Borsellino G, Battistini L, Sassoon D, et al. Fibroadipogenic progenitors mediate the ability of HDAC inhibitors to promote regeneration in dystrophic muscles of young, but not old Mdx mice. EMBO Mol Med 2013; 5(4):626-39; PMID:23505062; http://dx.doi.org/10.1002/emmm.201202096
   PubMed Web of Science ®Google Scholar
• Desguerre I, Mayer M, Leturcq F, Barbet JP, Gherardi RK, Christov C. Endomysial fibrosis in Duchenne muscular dystrophy: a marker of poor outcome associated with macrophage alternative activation. J Neuropathol Exp Neurol 2009; 68(7):762-73; PMID:19535995; http://dx.doi.org/10.1097/NEN.0b013e3181aa31c2
   PubMed Web of Science ®Google Scholar
• Joe AW, Yi L, Natarajan A, Le Grand F, So L, Wang J, Rudnicki MA, Rossi FM. Muscle injury activates resident fibroadipogenic progenitors that facilitate myogenesis. Nat Cell Biol 2010; 2:153-63; PMID:20081841; http://dx.doi.org/10.1038/ncb2015
   PubMed Web of Science ®Google Scholar
• Uezumi A, Fukada S, Yamamoto N, Takeda S, Tsuchida K. Mesenchymal progenitors distinct from satellite cells contribute to ectopic fat cell formation in skeletal muscle. Nat Cell Biol 2010; 2:143-52; PMID:20081842; http://dx.doi.org/10.1038/ncb2014
   PubMed Web of Science ®Google Scholar
• Judson RN, Zhang RH, Rossi FM. Tissue-resident mesenchymal stemprogenitor cells in skeletal muscle: collaborators or saboteurs? FEBS J 2013; 280(17):4100-8; PMID:23763717; http://dx.doi.org/10.1111/febs.12370
   PubMed Web of Science ®Google Scholar
• Malecova B, Puri PL. “Mix of Mics”- phenotypic and biological heterogeneity of “Multipotent” muscle interstitial cells (MICs). J Stem Cell Res Ther 2012; (Suppl 11):004; PMID:24634800; http://dx.doi.org/10.4172/2157-7633.S11-004
   PubMedGoogle Scholar
• Heredia JE, Mukundan L, Chen FM, Mueller AA, Deo RC, Locksley RM, Rando TA, Chawla A. Type 2 innate signals stimulate fibroadipogenic progenitors to facilitate muscle regeneration. Cell 2013;153(2):376-88; PMID:23582327; http://dx.doi.org/10.1016/j.cell.2013.02.053
   PubMed Web of Science ®Google Scholar
• Uezumi A, Ito T, Morikawa D, Shimizu N, Yoneda T, Segawa M, Yamaguchi M, Ogawa R, Matev MM, Miyagoe-Suzuki Y, et al. Fibrosis and adipogenesis originate from a common mesenchymal progenitor in skeletal muscle. J Cell Sci 2011; 124:3654-64; PMID:22045730; http://dx.doi.org/10.1242/jcs.086629
   PubMed Web of Science ®Google Scholar
• Giordani L, Puri PL. Epigenetic control of skeletal muscle regeneration: integrating genetic determinants and environmental changes. FEBS J 2013; 280(17):4014-25; PMID:23745685; http://dx.doi.org/10.1111/febs.12383
   PubMed Web of Science ®Google Scholar
• Minetti GC, Colussi C, Adami R, Serra C, Mozzetta C, Parente V, Fortuni S, Straino S, Sampaolesi M, Di Padova M, et al. Functional and morphological recovery of dystrophic muscles in mice treated with deacetylase inhibitors. Nat Med 2006; 12(10):1147-50; PMID:16980968; http://dx.doi.org/10.1038/nm1479
   PubMed Web of Science ®Google Scholar
• Colussi C, Mozzetta C, Gurtner A, Illi B, Straino S, Ragone G, Pescatori M, Zaccagnini G, Rosati G, Minetti G, et al. HDAC2 blockade by nitric oxide and histone deacetylase inhibitors reveals a common target in Duchenne muscular dystrophy treatment. Proc Natl Acad Sci 2008; 105(49):19183-7; PMID:19047631; http://dx.doi.org/10.1073/pnas.0805514105
   PubMed Web of Science ®Google Scholar
• Consalvi S, Mozzetta C, Bettica P, Germani M, Fiorentini F, Del Bene F, Rocchetti M, Leoni F, Monzani V, Mascagni P, et al. Preclinical studies in the mdx mouse model of duchenne muscular dystrophy with the histone deacetylase inhibitor givinostat. Mol Med 2013; 19:79-87; PMID:23552722; http://dx.doi.org/10.2119/molmed.2013.00011
   PubMed Web of Science ®Google Scholar
• Vianello S, Consolaro F, Bich C, Cancela JM, Roulot M, Lanchec E, Touboul D, Brunelle A, Israël M, Benoit E, et al. Low doses of arginine butyrate derivatives improve dystrophic phenotype and restore membrane integrity in DMD models. FASEB J 2014; 28(6):2603-19; PMID:24604079; http://dx.doi.org/10.1096/fj.13-244798
   PubMed Web of Science ®Google Scholar
• Johnson NM, Farr GH, Maves L. The HDAC inhibitor TSA ameliorates a zebrafish model of duchenne muscular dystrophy. PLoS Curr 2013; PMID:24459606; http://dx.doi.org/10.1371/currents.md.8273cf41db10e2d15dd3ab827cb4b027
   PubMedGoogle Scholar
• Saccone V, Consalvi S, Giordani L, Mozzetta C, Barozzi I, Sandoná M, Ryan T, Rojas-Muñoz A, Madaro L, Fasanaro P, et al. HDAC-regulated myomiRs control BAF60 variant exchange and direct the functional phenotype of fibro-adipogenic progenitors in dystrophic muscles. Genes Dev 2014; 28(8):841-57; PMID:24682306; http://dx.doi.org/10.1101/gad.234468.113
   PubMed Web of Science ®Google Scholar
• Wu JI, Lessard J, Crabtree GR. Understanding the words of chromatin regulation. Cell 2009; 136(2):200-6; PMID:19167321; http://dx.doi.org/10.1016/j.cell.2009.01.009
   PubMed Web of Science ®Google Scholar
• Puri PL, Mercola M. BAF60 A, B, and Cs of muscle determination and renewal. Genes Dev 2012; 26(24):2673-83; PMID:23222103; http://dx.doi.org/10.1101/gad.207415.112
   PubMed Web of Science ®Google Scholar
• de la Serna IL, Ohkawa Y, Imbalzano AN. Chromatin remodelling in mammalian differentiation: lessons from ATP-dependent remodellers. Nat Rev Genet 2006; 7:461-73; PMID:16708073; http://dx.doi.org/10.1038/nrg1882
   PubMed Web of Science ®Google Scholar
• Simone C, Forcales SV, Hill DA, Imbalzano AN, Latella L, Puri PL. p38 pathway targets SWI-SNF chromatin-remodeling complex to muscle-specific loci. Nat Genet 2004; 36:738-43; PMID:15208625; http://dx.doi.org/10.1038/ng1378
   PubMed Web of Science ®Google Scholar
• Wang W, Xue Y, Zhou S, Kuo A, Cairns BR, Crabtree GR. Diversity and specialization of mammalian SWISNF complexes. Genes Dev 1996; 10(17):2117-30; PMID:8804307; http://dx.doi.org/10.1101/gad.10.17.2117
   PubMed Web of Science ®Google Scholar
• Albini S, Coutinho P, Malecova B, Giordani L, Savchenko A, Forcales SV, Puri PL. Epigenetic reprogramming of human embryonic stem cells into skeletal muscle cells and generation of contractile myospheres. Cell Rep 2013; 3:661-70; PMID:23478022; http://dx.doi.org/10.1016/j.celrep.2013.02.012
   PubMed Web of Science ®Google Scholar
• Lickert H, Takeuchi JK, Von Both I, Walls JR, McAuliffe F, Adamson SL, Henkelman RM, Wrana JL, Rossant J, Bruneau BG. Baf60c is essential for function of BAF chromatin remodelling complexes in heart development. Nature 2004; 432:107-112; PMID:15525990; http://dx.doi.org/10.1038/nature03071
   PubMed Web of Science ®Google Scholar
• Forcales SV, Albini S, Giordani L, Malecova B, Cignolo L, Chernov A, Coutinho P, Saccone V, Consalvi S, Williams R, et al. Signal-dependent incorporation of MyoDBAF60c into Brg1-based SWISNF chromatin-remodelling complex. EMBO J 2011; 31:301-16; PMID:22068056; http://dx.doi.org/10.1038/emboj.2011.391
   PubMed Web of Science ®Google Scholar
• Li S, Liu C, Li N, Hao T, Han T, Hill DE, Vidal M, Lin JD. Genome-wide coactivation analysis of PGC-1a identifies BAF60a as a regulator of hepatic lipid metabolism. Cell Metab 2008; 8:105-117; PMID:18680712; http://dx.doi.org/10.1016/j.cmet.2008.06.013
   PubMed Web of Science ®Google Scholar
• Cacchiarelli D, Martone J, Girardi E, Cesana M, Incitti T, Morlando M, Nicoletti C, Santini T, Sthandier O, Barberi L, et al. MicroRNAs involved in molecular circuitries relevant for the duchenne muscular dystrophy pathogenesis are controlled by the dystrophinnNOS pathway. Cell Metab 2010; 12:341-51; PMID:20727829; http://dx.doi.org/10.1016/j.cmet.2010.07.008
   PubMed Web of Science ®Google Scholar
• Sokol NS, Ambros V. Mesodermally expressed Drosophila microRNA-1 is regulated by Twist and is required in muscles during larval growth. Genes Dev 2005; 19(19):2343-54; PMID:16166373; http://dx.doi.org/10.1101/gad.1356105
   PubMed Web of Science ®Google Scholar
• Chen JF, Mandel EM, Thomson JM, Wu Q, Callis TE, Hammond SM, Conlon FL, Wang DZ. The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat Genet 2006; 38(2):228-33; PMID:16380711; http://dx.doi.org/10.1038/ng1725
   PubMed Web of Science ®Google Scholar
• Kim HK, Lee YS, Sivaprasad U, Malhotra A, Dutta A. Muscle-specific microRNA miR-206 promotes muscle differentiation. J Cell Biol 2006; 174(5):677-87; PMID:16923828; http://dx.doi.org/10.1083/jcb.200603008
   PubMed Web of Science ®Google Scholar
• Vignier N, Amor F, Fogel P, Duvallet A, Poupiot J, et al. Distinctive serum miRNA profile in mouse models of striated muscular pathologies. PLoS One 2013; 8(2):e55281; PMID:23418438; http://dx.doi.org/10.1371/journal.pone.0055281
   PubMed Web of Science ®Google Scholar
• Roberts TC, Blomberg KEM, McClorey G, Andaloussi SE, Godfrey C, et al. Expression analysis in multiple muscle groups and serum reveals complexity in the MicroRNA transcriptome of the mdx mouse with implications for therapy. Mol Ther - Nucleic Acids 2012 1:e39; PMID:23344181
   PubMedGoogle Scholar
• Cacchiarelli D, Legnini I, Martone J, Cazzella V, D’Amico A, Bertini E, Bozzoni I. miRNAs as serum biomarkers for Duchenne muscular dystrophy. EMBO Mol Med 2011; 3(5):258-65; PMID:21425469; http://dx.doi.org/10.1002/emmm.201100133
   PubMed Web of Science ®Google Scholar
• Eisenberg I, Alexander MS, Kunkel LM. miRNAS in normal and diseased skeletal muscle. J Cell Mol Med 2009; 13(1):2-11; PMID:19175696; http://dx.doi.org/10.1111/j.1582-4934.2008.00524.x
   PubMed Web of Science ®Google Scholar
• Williams AH, Liu N, van Rooij E, Olson EN. MicroRNA control of muscle development and disease. Curr Opin Cell Biol 2009; 21(3):461-9; PMID:19278845; http://dx.doi.org/10.1016/j.ceb.2009.01.029
   PubMed Web of Science ®Google Scholar
• Greco S, De Simone M, Colussi C, Zaccagnini G, Fasanaro P, Pescatori M, Cardani R, Perbellini R, Isaia E, Sale P, et al. Common micro-RNA signature in skeletal muscle damage and regeneration induced by Duchenne muscular dystrophy and acute ischemia. FASEB J 2009; 23(10):3335-46; PMID:19528256; http://dx.doi.org/10.1096/fj.08-128579
   PubMed Web of Science ®Google Scholar
• Goljanek-Whysall K, Mok GF, Fahad Alrefaei A, Kennerley N, Wheeler GN, Münsterberg A. MyomiR-dependent switching of BAF60 variant incorporation into Brg1 chromatin remodeling complexes during embryo myogenesis. Development 2014; 141(17):3378-87; PMID:25078649; http://dx.doi.org/10.1242/dev.108787
   PubMed Web of Science ®Google Scholar
• Forterre A, Jalabert A, Chikh K, Pesenti S, Euthine V, Granjon A, Errazuriz E, Lefai E, Vidal H, Rome S. Myotube-derived exosomal miRNAs downregulate Sirtuin1 in myoblasts during muscle cell differentiation. Cell Cycle 2014; 13(1):78-89; PMID:24196440; http://dx.doi.org/10.4161/cc.26808
   PubMed Web of Science ®Google Scholar
• He WA, Calore F, Londhe P, Canella A, Guttridge DC, Croce CM. Microvesicles containing miRNAs promote muscle cell death in cancer cachexia via TLR7. Proc Natl Acad Sci U S A 2014; 111(12):4525-9; PMID:24616506; http://dx.doi.org/10.1073/pnas.1402714111
   PubMed Web of Science ®Google Scholar
• Lessard J, Wu JI, Ranish JA, Wan M, Winslow MM, Staahl BT, Wu H, Aebersold R, Graef IA, Crabtree GR. An essential switch in subunit composition of a chromatin remodeling complex during neural development. Neuron 2007; 55:201-15; PMID:17640523; http://dx.doi.org/10.1016/j.neuron.2007.06.019
   PubMed Web of Science ®Google Scholar
• Yoo AS, Sun AX, Li L, Shcheglovitov A, Portmann T, Li Y, Lee-Messer C, Dolmetsch RE, Tsien RW, Crabtree GR. MicroRNA-mediated conversion of human fibroblasts to neurons. Nature 2011; 476:228-31; PMID:21753754; http://dx.doi.org/10.1038/nature10323
   PubMed Web of Science ®Google Scholar
• Mizuno H, Nakamura A, Aoki Y, Ito N, Kishi S, Yamamoto K, Sekiguchi M, Takeda S, Hashido K. Identification of muscle-specific microRNAs in serum of muscular dystrophy animal models: promising novel blood-based markers for muscular dystrophy. PLoS One 2011; 6(3):e18388; PMID:21479190; http://dx.doi.org/10.1371/journal.pone.0018388
   PubMed Web of Science ®Google Scholar
• Vickers KC, Palmisano BT, Shoucri BM, Shamburek RD, Remaley AT MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat Cell Biol 2011 13:423-33; PMID:21423178; http://dx.doi.org/10.1038/ncb2210
   PubMed Web of Science ®Google Scholar
• Roberts TC, Godfrey C, McClorey G, Vader P, Briggs D, et al. Extracellular microRNAs are dynamic non-vesicular biomarkers of muscle turnover. Nucl Acids Res 2013 41:9500-13; PMID:23945935; http://dx.doi.org/10.1093/nar/gkt724
   PubMed Web of Science ®Google Scholar
• Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O’Briant KC, Allen A, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 2008; 105:10513-8; PMID:18663219; http://dx.doi.org/10.1073/pnas.0804549105
   PubMed Web of Science ®Google Scholar
• Vlassov AV, Magdaleno S, Setterquist R, Conrad R. Exosomes: current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials. Biochim Biophys Acta 2012; 1820:940-8; PMID:22503788; http://dx.doi.org/10.1016/j.bbagen.2012.03.017
   PubMed Web of Science ®Google Scholar
• Borges FT, Melo SA, Ozdemir BC, Kato N, Revuelta I, Miller CA, Gattone VH, Lebleu VS, Kalluri R. TGF-β1-containing exosomes from injured epithelial cells activate fibroblasts to initiate tissue regenerative responses and fibrosis. J Am Soc Nephrol. 2013; 24:385-92; PMID:23274427; http://dx.doi.org/10.1681/ASN.2012101031
   PubMed Web of Science ®Google Scholar
• Roberts TC, Coenen-Stass AM, Betts CA, Wood MJ. Detection and quantification of extracellular microRNAs in murine biofluids. Biol Proced Online 2014; 16(1):5; PMID:24629058; http://dx.doi.org/10.1186/1480-9222-16-5
   PubMed Web of Science ®Google Scholar
• Roberts TC, Coenen-Stass AM, Wood MJ. Assessment of RT-qPCR normalization strategies for accurate quantification of extracellular microRNAs in murine serum. PLoS One 2014; 9(2):e89237; PMID:24586621; http://dx.doi.org/10.1371/journal.pone.0089237
   PubMed Web of Science ®Google Scholar
• Goyenvalle A, Babbs A, Wright J, Wilkins V, Powell D, et al. Rescue of severely affected dystrophinutrophin-deficient mice through scAAV-U7snRNA-mediated exon skipping. Hum Mol Genet 2012; 21:2559-71; PMID:22388933; http://dx.doi.org/10.1093/hmg/dds082
   PubMed Web of Science ®Google Scholar